Although the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) recommendations on RA predominantly focus on early phases of the disease and on pharmacological management, a sizeable portion of patients can be characterised as difficult-to-treat (estimated prevalence around 5-20%). In order to develop adequate guidelines and recommendations for this population, a difficult-to-treat RA classification needs to be defined.
Roodenrijs et al. set out to define characteristics of difficult-to-treat RA patients via an online survey among rheumatologists.  This questionnaire consisted of 9 questions regarding the background of the respondents, aspects to be included in the definition of difficult-to-treat RA, and missing items on its comprehensive management in the current EULAR management recommendations.
Respondents answered questions on the necessity of incorporating the following items into the definition: disease activity level...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Biologic Drug Levels and Infection Risk, and Clinical Effectiveness of Sarilumab Next Article
Low Bone Mineral Density Is Common in Axial Spondyloarthritis; More Awareness Required »
Table of Contents: EULAR 2018
Psoriasis and Psoriatic Arthritis
Osteoporosis and Osteoarthritis
Systemic Sclerosis and Systemic Lupus Erythematosus
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.